Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0115 | 0.0115 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0688 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0117 | 0.1516 | 0.1516 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0033 | 0.0256 | 0.1003 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0115 | 0.4314 |
Echinococcus granulosus | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Plasmodium falciparum | pyruvate kinase 2 | 0.0017 | 0.0019 | 0.0019 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0115 | 0.0115 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.1946 | 0.1946 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0115 | 0.0115 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.0459 | 0.0459 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Echinococcus multilocularis | geminin | 0.0166 | 0.2238 | 0.2238 |
Giardia lamblia | Pyruvate kinase | 0.0033 | 0.0256 | 0.0247 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0.0028 | 0.0783 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0115 | 0.4314 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0033 | 0.0256 | 0.0256 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0.0028 | 0.0028 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0688 | 1 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0016 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0115 | 0.0115 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0294 | 0.0187 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0016 | 0.0009 | 0.0009 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0046 | 0.0459 | 0.0459 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0028 | 0.0028 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0115 | 0.0115 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0016 | 0.0009 | 0.0009 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0033 | 0.0256 | 0.0256 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0033 | 0.0256 | 0.0256 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0688 | 1 | 1 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0033 | 0.0256 | 0.0256 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0046 | 0.0459 | 0.0459 |
Onchocerca volvulus | 0.0148 | 0.1971 | 0.1877 | |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0115 | 0.4314 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0209 | 0.2884 | 0.2884 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0688 | 1 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0115 | 0.0007 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0688 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0106 | 0.1341 | 0.1341 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0115 | 0.4314 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0115 | 0.0115 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0016 | 0.0009 | 0.0009 |
Schistosoma mansoni | hypothetical protein | 0.0166 | 0.2238 | 0.2238 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.0459 | 0.0459 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0016 | 0.0009 | 0.0009 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0294 | 0.0294 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0294 | 0.0294 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0023 | 0.0115 | 0.0007 |
Toxoplasma gondii | pyruvate kinase PyKII | 0.0017 | 0.0019 | 0.0019 |
Echinococcus multilocularis | pyruvate kinase | 0.0026 | 0.0153 | 0.0153 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0.0028 | 0.0028 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0256 | 0.0256 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0016 | 0.0009 | 0.0009 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0016 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.1946 | 0.1946 |
Schistosoma mansoni | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Giardia lamblia | Pyruvate kinase | 0.0017 | 0.0019 | 0.0011 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0014 | 0.0014 |
Plasmodium falciparum | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0294 | 0.0187 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0117 | 0.1516 | 0.1516 |
Plasmodium vivax | pyruvate kinase 2, putative | 0.0017 | 0.0019 | 0.0019 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1971 | 0.1971 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0023 | 0.0109 | 0.0109 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0106 | 0.1341 | 0.1341 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.0459 | 0.0459 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0294 | 0.0294 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0033 | 0.0256 | 0.0247 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0688 | 1 | 1 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0688 | 1 | 1 |
Plasmodium vivax | pyruvate kinase, putative | 0.0033 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0028 | 0.0028 |
Toxoplasma gondii | thioredoxin reductase | 0.0046 | 0.0459 | 0.0459 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0016 | 0.0009 | 0.0009 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0115 | 0.0115 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0294 | 0.0187 |
Leishmania major | trypanothione reductase | 0.0046 | 0.0459 | 0.0459 |
Trypanosoma brucei | trypanothione reductase | 0.0046 | 0.0459 | 0.0459 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.0459 | 0.0459 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0115 | 0.0007 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0688 | 1 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0028 | 0.0028 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0046 | 0.0459 | 0.0459 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0688 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0294 | 0.0294 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 0.1946 | 0.1946 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0688 | 1 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0688 | 1 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0117 | 0.1516 | 0.1516 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Brugia malayi | glutathione reductase | 0.0046 | 0.0459 | 0.0459 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0106 | 0.1341 | 0.1341 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0688 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0294 | 0.0187 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0014 | 0.0014 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0688 | 1 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0106 | 0.1341 | 0.1341 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0117 | 0.1516 | 1 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0033 | 0.0256 | 0.0247 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | pyruvate kinase | 0.0033 | 0.0256 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0115 | 0.0115 |
Plasmodium falciparum | glutathione reductase | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0115 | 0.4314 |
Schistosoma mansoni | hypothetical protein | 0.0166 | 0.2238 | 0.2238 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0256 | 0.0142 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0109 | 0.0109 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 0.1946 | 0.1946 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0294 | 0.0294 |
Echinococcus granulosus | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0009 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0115 | 0.4314 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0115 | 0.0115 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0019 | 0.0019 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0115 | 0.0115 |
Loa Loa (eye worm) | hypothetical protein | 0.0688 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0688 | 1 | 1 |
Plasmodium vivax | RNA helicase-1, putative | 0.0688 | 1 | 1 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0688 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0009 | 0.0009 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.0459 | 0.0459 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0688 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0115 | 0.4314 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.0459 | 0.0459 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0016 | 0.0009 | 0.0009 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0256 | 0.0256 |
Brugia malayi | hypothetical protein | 0.0148 | 0.1971 | 0.1971 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0216 | 0.2975 | 0.2975 |
Brugia malayi | Muscleblind-like protein | 0.0146 | 0.1946 | 0.1946 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0256 | 0.0256 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0688 | 1 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0106 | 0.1341 | 0.1341 |
Echinococcus granulosus | muscleblind protein | 0.0146 | 0.1946 | 0.1946 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0688 | 1 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0106 | 0.1341 | 0.8749 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0256 | 0.0142 |
Plasmodium falciparum | thioredoxin reductase | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0046 | 0.0459 | 0.0459 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0033 | 0.0256 | 0.0256 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0017 | 0.0028 | 0.0783 |
Echinococcus granulosus | geminin | 0.0166 | 0.2238 | 0.2238 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0688 | 1 | 1 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0688 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0688 | 1 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0014 | 0.0014 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0256 | 0.0142 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0028 | 0.0028 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0106 | 0.1341 | 0.1341 |
Chlamydia trachomatis | pyruvate kinase | 0.0033 | 0.0256 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0115 | 0.0115 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0115 | 0.4314 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0016 | 0.0009 | 0.0009 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0014 | 0.0014 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0009 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.0459 | 0.0459 |
Echinococcus granulosus | mitogen-activated protein kinase kinase kinase 9 | 0.0216 | 0.2975 | 0.2975 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0033 | 0.0256 | 0.0256 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 12 uM | Activation of PPAR (unknown origin) transactivation expressed in human HepG2 cells assessed as increase in transcriptional activity after 20 hrs by PPRE-luciferase reporter gene assay | ChEMBL. | 26707398 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.